TCM
ROIV icon

Tyro Capital Management’s Roivant Sciences ROIV Stock Holding History

Tyro Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,465,377
Closed -$24.9M – 15
2025
Q1 		$24.9M Buy
2,465,377
+357,094
+17% +$3.86M 9.27% 5
2024
Q4 		$24.9M Buy
2,108,283
+353,307
+20% +$4.18M 8.17% 6
2024
Q3 		$20.3M Buy
1,754,976
+10,649
+0.6% +$121K 6.53% 5
2024
Q2 		$18.4M Buy
1,744,327
+248,733
+17% +$2.73M 8.36% 4
2024
Q1 		$15.8M Buy
1,495,594
+149,613
+11% +$1.61M 9.1% 6
2023
Q4 		$15.1M Buy
+1,345,981
New +$13.1M 10.65% 3

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Tyro Capital Management's ROIV Position: Q2 2025 in Review

Tyro Capital Management sold out of Roivant Sciences (ROIV) in Q2 2025, closing a stake of 2,465,377 shares — an estimated $24.9M sold.

Tyro Capital Management first reported a position in ROIV in Q4 2023 and held it in 6 quarters. The position peaked at $24.9M in Q4 2024. 338 funds tracked by Wall St. Rank hold ROIV as of Q2 2025.

  • Tyro Capital Management reported no remaining Roivant Sciences position as of Q2 2025 after selling out during the quarter.
  • Tyro Capital Management sold 2,465,377 Roivant Sciences shares in Q2 2025, an estimated $24.9M.
  • Tyro Capital Management first reported a position in Roivant Sciences in Q4 2023 and held it in 6 quarters.
  • Tyro Capital Management's Roivant Sciences position peaked at $24.9M in Q4 2024.
  • 338 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2025.

Based on Tyro Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.